Find your path to Mike
280 people in our graph share verified history with Mike — schools, employers, funds. One of them is your warm intro.
Richard RansohoffunlockedMike: together at Cleveland Clinic (1997–1998)
Mike: together at BlueRock
×2Mike: together at Novo Nordisk
Mike: together at Edwards Lifesciences
About
Mike Scott is Chief Development Officer at Aspect Biosystems, where he leads the development of cellular medicines that combine therapeutic cells with 3D bioprinting and hypoimmune cell engineering, guiding them toward regulatory approval and clinical trials. His prior work spans cell therapies, medical devices, and combination products across therapeutic areas including Parkinson's disease, heart failure, diabetes, and eye diseases, with roles at Novo Nordisk, BlueRock, ViaCyte, Edwards Lifesciences, and Orqis Medical. At Edwards Lifesciences, he served as Manager of Advanced Heart Valve Therapy Technologies and led a cross-functional team that brought a bioprosthetic valve to market in the European Union and Canada in 2002 and the U.S. in 2003.
Chief Development Officer at Aspect Biosystems
Intro paths
→
In turn, Mike can intro founders to Aspect Biosystems's investors below.
Aspect Biosystems's investors · 11
Angel ForumVancouverCivilization Ventures Management, LlcTiburon · $1M – $10M checksDimension CapitalSan Francisco · $1M – $10M checksInBC Investment Corp.British Columbia · $3M – $10M checksJDRF T1D FundBostonPage One VenturesSilicon ValleyPallasite VenturesVancouver · $100K – $1.5M checksPangaea Ventures Us Inc.Vancouver · $500K – $1.5M checksRadical VenturesToronto · $1M – $25M checksRelentless Pursuit PartnersVancouverRising TidePacifica
Co-founders at Aspect Biosystems
TM
Tamer MohamedFounder & CEO
SW
Sam WadsworthCo-founder & Chief Scientific Officer
SB
Simon BeyerCo-founder & Chief Technology Officer
Experience
- Aspect BiosystemsChief Development Officercurrent2026 — presentFremont, CA
- Great Lakes RehabilitationPresident & CEO2020 — 2026Simcoe, ON
- Novo NordiskVice President, Cell Therapy Medical Devices2021 — 2026Fremont, California, United States
- BlueRock TherapeuticsSenior Vice President Of Product Development2017 — 2021Toronto, Canada Area
- ViaCyteChief Development Officer & Vice President, R&D2011 — 2017San Diego
- Edwards LifesciencesSr. Director, Engineering2009 — 2011
- Orqis MedicalVice President of R&D2003 — 2009
- Edwards LifesciencesManager II, Advanced Heart Valve Therapy Technology2002 — 2003
- Edwards LifesciencesEngineering Specialist / Manager of Biomechanics2000 — 2002
- Baxter HealthcareProject Engineer / Manager of Biomechanics1998 — 2000
- Cleveland ClinicProject Engineer1997 — 1998
Skills & more
Medical Devices65Program Management5Design Control29ISO 134859Cardiology3Biomedical Engineering22Commercialization11Technology Evaluation1FDA41cardiac surgerybiomaterialsexperimental design
+8 more
bioengineeringbiotechnologyISO 14971engineering managementManufacturingquality systemBiotechnologyQuality SystemLanguages English · French (just enough to be dangerous)
From Mike's professional profile.
Frequently asked questions
- Who is Mike Scott?
- Mike Scott is Chief Development Officer at Aspect Biosystems, where he leads the development of cellular medicines that combine therapeutic cells with 3D bioprinting and hypoimmune cell engineering, guiding them toward regulatory approval and clinical trials. His prior work spans cell therapies, medical devices, and combination products across therapeutic areas including Parkinson's disease, heart failure, diabetes, and eye diseases, with roles at Novo Nordisk, BlueRock, ViaCyte, Edwards Lifesciences, and Orqis Medical. At Edwards Lifesciences, he served as Manager of Advanced Heart Valve Therapy Technologies and led a cross-functional team that brought a bioprosthetic valve to market in the European Union and Canada in 2002 and the U.S. in 2003.
- Where does Mike Scott work?
- Mike Scott is Chief Development Officer at Aspect Biosystems.
- Where did Mike Scott go to school?
- Mike Scott studied at Western University (Ph.D., Medical Biophysics); University of Waterloo (M.A.Sc., Civil (Biomedical) Engineering); University of Waterloo (B.A.Sc., Civil Engineering (Management Science)).
Same school
Also attended Western University407
Jasmine YangVice President at Sapphire VenturesKevin GaburaInvestor at Craft VenturesTanuj DuttaGeneral Partner at Congruent VenturesLindsay HamiltonInvestment Manager - Finance at Emerald Technology Ventures AgMichelle KwokPrincipal at Draper AssociatesJenny HeFounder & General Partner at Position Ventures
+ 401 more
Also attended University of Waterloo645
Chamath PalihapitiyaFounder & CEO of Social CapitalApoorva MehtaFounder of Instacart; founder of Cloud Health SystemsAchintya ChaudhariInvestor at LightbankKarim GillaniGeneral Partner at Luge CapitalRohan MongaInvestment Associate at Luge CapitalAndrew MiklasGeneral Partner at Y Combinator
+ 639 more
Shared employers
Also worked at Aspect Biosystems9
Andrew HaughianPartner at Pangaea Ventures Us Inc.Janelle GoulardPartner at Pangaea Ventures Us Inc.Daniel MuletPartner at Radical VenturesSalim TejaPartner, Head of Velocity Team at Radical VenturesMo El-BibanyGeneral Partner at Page One VenturesChristopher BissonnetteManaging Partner at Pallasite Ventures
+ 3 more
Also worked at Novo Nordisk70
Jesper GromadaInvestor at Third Rock VenturesKevin GroveVenture Partner at Versant VenturesEmilia CarlqvistAnalyst, Innovestor Life Science at Innovestor VenturesBrian DanielsVenture Partner at 5AM VenturesKasim KutayCEO at Novo HoldingsTaruho KurodaImpact Partner at Fresco Capital
+ 64 more
